Profile
David Chamberlain is the founder of Hyperchip, Inc. which was founded in 1997.
He also worked as a Co-Creator at Xenogen Corp.
Mr. Chamberlain received an undergraduate degree from Concordia University.
Former positions of David Chamberlain
| Companies | Position | End |
|---|---|---|
Hyperchip, Inc.
 Hyperchip, Inc. Information Technology ServicesTechnology Services Hyperchip Inc. offers network routing components and systems including Hyperchip FPGA Cores and Architectures. The Hyperchip H40G Router is a 40 Gb/s router over five times less power consuming, over 10 times smaller and a fraction of the cost of incumbents, using industry standard MicroTCA chassis and open-standard interfaces. In the future Hyperchip will extend its offerings from 40Gb/s to 100Gb/s per MicroTCA chassis and per ATCA slot with in-service scaling from a single line card to full non-blocking multi-chassis systems, across the network industry from high-speed access networks to scalable core routers. | Founder | 2011-10-10 |
Xenogen Corp.
 Xenogen Corp. Medical SpecialtiesHealth Technology Xenogen Corp. provides real time in-vivo imaging services and genetic modification technologies. Its products and technologies include an imaging system, software, and biological materials. Its solutions are designed to improve discovery and pre-clinical research in multiple therapeutic areas. The company was founded by Pamela Reilly Contag and Christopher H. Contag in 1995 and is headquartered in Alameda, CA. | Corporate Officer/Principal | - |
Training of David Chamberlain
| Concordia University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Hyperchip, Inc.
Hyperchip, Inc. Information Technology ServicesTechnology Services Hyperchip Inc. offers network routing components and systems including Hyperchip FPGA Cores and Architectures. The Hyperchip H40G Router is a 40 Gb/s router over five times less power consuming, over 10 times smaller and a fraction of the cost of incumbents, using industry standard MicroTCA chassis and open-standard interfaces. In the future Hyperchip will extend its offerings from 40Gb/s to 100Gb/s per MicroTCA chassis and per ATCA slot with in-service scaling from a single line card to full non-blocking multi-chassis systems, across the network industry from high-speed access networks to scalable core routers. | Technology Services |
Xenogen Corp.
Xenogen Corp. Medical SpecialtiesHealth Technology Xenogen Corp. provides real time in-vivo imaging services and genetic modification technologies. Its products and technologies include an imaging system, software, and biological materials. Its solutions are designed to improve discovery and pre-clinical research in multiple therapeutic areas. The company was founded by Pamela Reilly Contag and Christopher H. Contag in 1995 and is headquartered in Alameda, CA. | Health Technology |
- Stock Market
- Insiders
- David Chamberlain
